The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms
Background: Chronic kidney disease (CKD), driven by progressive renal fibrosis, lacks effective therapeutic targets. This study investigates thrombospondin-4 (THBS4) as a novel mediator of CKD-related fibrosis and explores its mechanistic basis....
Saved in:
| Main Authors: | Xu Yan, Kun Zhao, Ye Yao, Lihui Wang, Wei Shan, Yan Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-07-01
|
| Series: | Frontiers in Bioscience-Landmark |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/FBL/30/7/10.31083/FBL26076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aloe-emodin ameliorates chronic kidney disease fibrosis by inhibiting PI3K-mediated signaling pathway
by: Ming Chen, et al.
Published: (2025-08-01) -
Screening of active components in Astragalus mongholicus Bunge and Panax notoginseng formula for anti-fibrosis in CKD: nobiletin inhibits Lgals1/PI3K/AKT signaling to improve renal fibrosis
by: Fang Yang, et al.
Published: (2024-12-01) -
Cyanidin-3-glucoside upregulated NDRG2 through the PI3K/AKT pathway to alleviate EMT and ECM in renal fibrosis
by: Qianxue Lu, et al.
Published: (2025-03-01) -
PI3K/Akt in IPF: untangling fibrosis and charting therapies
by: Janki Bhatt, et al.
Published: (2025-03-01) -
Mechanism of DNASE1L3 delaying renal fibrosis by inhibiting PI3K-AKT signaling pathway
by: WEI Xiao, et al.
Published: (2025-05-01)